MTOR and cancer: mTORC1/2 are frequently activated in human cancers via mutation of upstream negative regulators such as PTEN or TSC2. Following mTOR activation, DEPTOR is phosphorylated by mTOR, which in turn leads to phosphorylation of DEPTOR by CK1 (refs 26, 27).